Search Within

Amy Zhu

Formats
  1. Journal Article (4)
  2. Meeting Abstract (3)
  3. Book Section (1)
Groups
  1. Surgery (8)
  2. Department of Medicine (6)
  3. Solid Tumor Oncology Division (5)
  4. Thoracic Oncology (5)
  5. Center for Hematologic Malignancies (4)
  6. Center for Pancreatic Cancer Research (4)

More Groups

People
  1. Prasad Adusumilli (8)
  2. Valerie Rusch (6)
  3. David Jones (5)
  4. Marjorie Zauderer (5)
  5. Isabelle Riviere (4)
  6. John Pineda (4)

More People

Years
  1. 2023 (2)
  2. 2022 (2)
  3. 2021 (2)
  4. 2019 (2)
Publications
  1. Annals of Oncology (1)
  2. Annals of Surgery (1)
  3. Cancer Discovery (1)
  4. Cancer Research (1)
  5. JTO Clinical and Research Reports (1)
  6. Journal of Clinical Oncology (1)

More Publications

Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. Elsevier BV (1)
  4. Elsevier Inc. (1)
  5. Elsevier Ireland Ltd. (1)
  6. Lippincott Williams & Wilkins (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A prospective clinical trial to evaluate mesothelin as a biomarker for the clinical management of patients with esophageal adenocarcinoma
    Journal Article

    Byun, A. J.; Grosser, R. A.; Choe, J. K.; Rizk, N. P.; Tang, L. H.; Molena, D.; Tan, K. S.; Restle, D.; Cheema, W.; Zhu, A.; more...
    Annals of Surgery (2023)

    Fulltext@MSK | Save
  • Immunotherapy using CAR T: What we have learned from trials and where we are heading
    Book Section

    Zhu, A.; Bellis, R.; Saini, J.; Fong, C.; Adusumilli, P. S.
    In Jewett, A.; Fong, Y. (Eds.) NK Cells in Cancer Immunotherapy: Successes and Challenges (2023)

    Fulltext@MSK | Save
  • Brief report: Contralateral lobectomy for second primary NSCLC: Perioperative and long-term outcomes
    Journal Article

    Choe, J. K.; Zhu, A.; Byun, A. J.; Zheng, J.; Tan, K. S.; Dycoco, J.; Bains, M. S.; Bott, M. J.; Downey, R. J.; Huang, J.; more...
    JTO Clinical and Research Reports (2022)

    Fulltext@MSK | Save
  • Image-guided interventional radiological delivery of chimeric antigen receptor (CAR) T cells for pleural malignancies in a phase I/II clinical trial
    Journal Article

    Ghosn, M.; Cheema, W.; Zhu, A.; Livschitz, J.; Maybody, M.; Boas, F. E.; Santos, E.; Kim, D.; Beattie, J. A.; Offin, M.; more...
    Lung Cancer (2022)

    Fulltext@MSK | Save
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; RivieĢ€re, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save